Morbidity and Mortality of COVID in Relation to Age, Sex and BMI


  • Mysore S. Bhagavan Internal Medicine Doctor, Internal Medicine, Loretto Hospital, 645 South Central Ave, Chicago IL, 60644, USA
  • Srikrishna C. Karnatapu All Saints University School of Medicine, Hillsborough St, Roseau, Dominica
  • Saloni Doke Spartan Health Sciences University, Spartan Drive, St. Jude's Highway, St. Lucia
  • Theourrn Amalathasan All Saints University School of Medicine, Hillsborough St, Roseau, Dominica
  • Thebuoshon Amalathasan All Saints University School of Medicine, Hillsborough St, Roseau, Dominica
  • Chiraag Ashokkumar Spartan Health Sciences University, Spartan Drive, St. Jude's Highway, St. Lucia



COVID-19, Obesity, SARS-CoV-2, Mortality, Coronavirus, Pandemic, Sex


The United States (US) has been the epicenter of the Coronavirus disease pandemic (COVID-19). The underrepresented minorities which tend to have a higher prevalence of obesity are affected disproportionately. The objective of this study was to assess the early outcomes and characteristics of COVID-19 patients in the US and also investigate whether age, gender, and obesity are associated with worse outcomes. To determine the effect of body mass index, sex, and age on risk for morbidity and mortality of COVID-19. Compressive systematic research was conducted to pool every relevant article that evaluated COVID’s effect on patients with regard to BMI, age, sex, and mortality. Search for articles was conducted in the most widely-used databases such as PubMed, Scopus, EMBASE, and Web of Science. Search terms used for article retrieval included: “BMI,” OR “Obesity,” OR “BMI,” OR “Sex,” OR “Age.” AND “COVID-19 related mortality.” Severe obesity, male sex, and increasing age are associated with a high rate of in-hospital mortality and generally, worse in-hospital prognosis.



Metrics Loading ...


Download data is not yet available.


Afshin, A., Forouzanfar, M.H., et al. (2017). Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med. 377(1), 13-27. DOI:

Baig, A.M., Khaleeq, A., Ali, U., Syeda, H. (2020). Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms. ACS Chem Neurosci., 11(7), 995-998. DOI:

Baud, D., Qi, X., Nielsen-Saines, K., Musso, D., Pomar, L., Favre, G. (2020). Real estimates of mortality following COVID-19 infection. Lancet Infect Dis., 20(7), 773. DOI:

Bello-Chavolla, O.Y., Bahena-López, J.P., Antonio-Villa, N.E., et al. (2020). Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico. J Clin Endocrinol Metab., 105(8), dgaa346. DOI:

Berumen, J., Schmulson, M., Alegre, J., et al. (2020). Risk of infection and hospitalization by Covid‐19 in Mexico: a case‐control study. medRxiv. DOI:

Bhatraju, P.K., Ghassemieh, B.J., Nichols, M., et al. (2020). Covid-19 in Critically Ill Patients in the Seattle Region - Case Series. New England Journal of Medicine, 382(21), 2012-2022. DOI:

Boccia, S., Ricciardi, W., Ioannidis, J.P.A. (2020). What Other Countries Can Learn From Italy During the COVID-19 Pandemic. JAMA Intern Med., 180(7), 927-928. DOI:

Cao, Y., Li, L., Feng, Z., et al. (2020). Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations. Cell Discov., 6(11). DOI:

Centers for Disease Control and Prevention. (2021). Adult obesity prevalence maps. Division of Nutrition, Physical Activity, and Obesity, National Center for Chronic Disease Prevention and Health Promotion.

Chen, G., Wu, D., Guo, W., et al. (2020). Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest., 130(5), 2620-2629. DOI:

Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., Xia, J., Yu, T., Zhang, X., Zhang, L. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet, 395(10223), 507–513. DOI:

Chiappelli, F. (2020). Towards Neuro-CoViD-19. Bioinformation, 16(4), 288-292. DOI:

Cho, E.R., Slutsky, A.S., Jha, P. (2020). Smoking and the risk of COVID‐19 infection in the UK Biobank Prospective Study. medRxiv. DOI:

County Health Rankings and Roadmaps. (2019). 2019 County Health Rankings Key Findings Report.

COVID Data Tracker. (2020). United States COVID-19 Cases, Deaths, and Laboratory Testing (NAATs) by State, Territory, and Jurisdiction. Centers for Disease Control and Prevention.

Crouch, M., Al-Shaer, A., Shaikh, S.R. (2021). Hormonal Dysregulation and Unbalanced Specialized Pro-Resolving Mediator Biosynthesis Contribute toward Impaired B Cell Outcomes in Obesity. Mol Nutr Food Res., 65(1), e1900924. DOI:

Darling, A.L., Ahmadi, K.R., Ward, K.A., et al. (2020). Vitamin D status, body mass index, ethnicity and COVID‐19: initial analysis of the first‐reported UK Biobank COVID‐19 positive cases (n 580) compared with negative controls (n 723). medRxiv. DOI:

de Lusignan, S., Dorward, J., Correa, A., et al. (2020). Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study. Lancet Infect Dis., 20(9), 1034-1042. DOI:

Díaz, E., Rodríguez, A., Martin-Loeches, I., et al. (2011). Impact of obesity in patients infected with 2009 influenza A(H1N1). Chest., 139(2), 382-386. DOI:

Elgendy, I.Y., Pepine, C.J. (2020). Why are women better protected from COVID-19: Clues for men? Sex and COVID-19. International Journal of Cardiology, 315, 105-106. DOI:

Ferrarese, C., Silani, V., Priori, A., et al. (2020). An Italian multicenter retrospective-prospective observational study on neurological manifestations of COVID-19 (NEUROCOVID). Neurol Sci., 41(6), 1355-1359. DOI:

Gao, F., Zheng, K.I., Wang, X.B., et al. (2020). Obesity Is a Risk Factor for Greater COVID-19 Severity. Diabetes Care, 43(7), e72-e74. DOI:

Gao, Z., Xu, Y., Sun, C., et al. (2021). A systematic review of asymptomatic infections with COVID-19. J Microbiol Immunol Infect., 54(1), 12-16. DOI:

Garibaldi, B.T., Fiksel, J., Muschelli, J., et al. (2021). Patient Trajectories Among Persons Hospitalized for COVID-19: A Cohort Study. Ann Intern Med., 174(1), 33-41. DOI:

Ghazeeri, G., Abdullah, L., Abbas, O. (2011). Immunological differences in women compared with men: overview and contributing factors. Am J Reprod Immunol., 66(3), 163-169. DOI:

Glende, J., Schwegmann-Wessels, C., Al-Falah, M., et al. (2008). Importance of cholesterol-rich membrane microdomains in the interaction of the S protein of SARS-coronavirus with the cellular receptor angiotensin-converting enzyme 2. Virology, 381(2), 215-221. DOI:

Gong, M.N., Bajwa, E.K., Thompson, B.T., Christiani, D.C. (2010). Body mass index is associated with the development of acute respiratory distress syndrome. Thorax, 65(1), 44-50. DOI:

Grasselli, G., Zangrillo, A., Zanella, A., et al. (2020). Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA, 323(16), 1574-1581. DOI:

Halamka, J., Cerrato, P., Perlman, A. (2020). Redesigning COVID-19 Care With Network Medicine and Machine Learning. Mayo Clin Proc Innov Qual Outcomes., 4(6), 725-732. DOI:

Hales, C.M., Carroll, M.D., Fryar, C.D., Ogden, C.L. (2020). Prevalence of Obesity and Severe Obesity Among Adults: United States, 2017-2018. NCHS Data Brief, 2020(360), 1-8.

Hanslik, T., Boelle, P.Y., Flahault, A. (2010). Preliminary estimation of risk factors for admission to intensive care units and for death in patients infected with A(H1N1)2009 influenza virus, France, 2009-2010. PLoS Curr., 2(RRN1150). DOI:

Ho, F.K., Celis‐Morales, C.A., Gray, S.R., et al. (2020). Modifiable and non‐modifiable risk factors for COVID‐19: results from UK Biobank. medRxiv. DOI:

Huttunen, R., Syrjänen, J. (2010). Obesity and the outcome of infection. Lancet Infect Dis., 10(7), 442-443. DOI:

Huttunen, R., Syrjänen, J. (2013). Obesity and the risk and outcome of infection. Int J Obes (Lond)., 37(3), 333-340. DOI:

ICNARC. (2020). ICNARC report on COVID‐19 in critical care 10 July 2020. ICNARC, London.

Jain, S., Chaves, S.S. (2011). Obesity and influenza. Clin Infect Dis., 53(5), 422-424. DOI:

Kantar. (2020). Covid‐19: wave 2, 27‐30 March among connected South African consumers. Kantar World Panel. Johannisberg.

Karlsson, E.A., Milner, J.J., Green, W.D., Rebeles, J., Schultz‐Cherry, S., Beck, M. (2019). Chapter 10—influence of obesity on the response to influenza infection and vaccination In: Johnston RA, Suratt BT, eds. Mechanisms and Manifestations of Obesity in Lung Disease. Cambridge, Massachusetts: Academic Press, 227‐259. DOI:

Karnam, G., Rygiel, T.P., Raaben, M., et al. (2012). CD200 receptor controls sex-specific TLR7 responses to viral infection. PLoS Pathog., 8(5), e1002710. DOI:

Kass, D.A., Duggal, P., Cingolani, O. (2020). Obesity could shift severe COVID-19 disease to younger ages. The Lancet, 395(10236), 1544-1545. DOI:

Khawaja, A.P., Warwick, A.N., Hysi, P.G., et al. (2020). Associations with covid‐19 hospitalisation amongst 406,793 adults: the UK Biobank prospective cohort study. medRxiv. DOI:

Klein, S.L., Flanagan, K.L. (2016). Sex differences in immune responses. Nat Rev Immunol., 16(10), 626-638. DOI:

Kompaniyets, L., Goodman, A.B., Belay, B., et al. (2021). Body Mass Index and Risk for COVID-19–Related Hospitalization, Intensive Care Unit Admission, Invasive Mechanical Ventilation, and Death — United States, March–December 2020. Morbidity and Mortality Weekly Report (MMWR), 70(10), 355–361. DOI:

Kris-Etherton, P.M., Taylor, D.S., Yu-Poth, S., et al. (2000). Polyunsaturated fatty acids in the food chain in the United States. Am J Clin Nutr., 71(1 Suppl), 179S-88S. DOI:

Lagunas-Rangel, F.A., Chávez-Valencia, V. (2020). High IL-6/IFN-γ ratio could be associated with severe disease in COVID-19 patients. J Med Virol., 92(10), 1789-1790. DOI:

Lalmuanawma, S., Hussain, J., Chhakchhuak, L. (2020). Applications of machine learning and artificial intelligence for Covid-19 (SARS-CoV-2) pandemic: A review. Chaos Solitons Fractals., 139(110059). DOI:

Leung, N.Y., Bulterys, M.A., Bulterys, P.L. (2020). Predictors of COVID‐19 incidence, mortality, and epidemic growth rate at the country level. medRxiv. DOI:

Li, W., Sui, J., Huang, I.C., et al. (2007). The S proteins of human coronavirus NL63 and severe acute respiratory syndrome coronavirus bind overlapping regions of ACE2. Virology., 367(2), 367-374. DOI:

Li, X., Xu, S., Yu, M., et al. (2020). Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol., 146(1), 110-118. DOI:

Lighter, J., Phillips, M., Hochman, S., et al. (2020). Obesity in Patients Younger Than 60 Years Is a Risk Factor for COVID-19 Hospital Admission. Clin Infect Dis., 71(15), 896-897. DOI:

Louie, J.K., Acosta, M., Samuel, M.C., et al. (2011). A novel risk factor for a novel virus: obesity and 2009 pandemic influenza A (H1N1). Clin Infect Dis., 52(3), 301-312. DOI:

Lu, R., Zhao, X., Li, J., et al. (2020). Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet, 395(10224), 565-574. DOI:

McKibbin, W.J., Fernando, R. (2020). The global macroeconomic impacts of COVID-19: seven scenarios. CAMA Working Paper No. 19/2020. The Australian National University, 1-43. DOI:

Mihrshahi, R., Barclay, A.N., Brown, M.H. (2009). Essential roles for Dok2 and RasGAP in CD200 receptor-mediated regulation of human myeloid cells. J Immunol., 183(8), 4879-4886. DOI:

Minaee, S., Kafieh, R., Sonka, M., Yazdani, S., Jamalipour Soufi, G. (2020). Deep-COVID: Predicting COVID-19 from chest X-ray images using deep transfer learning. Med Image Anal., 65(101794). DOI:

Montefiore's Office of Community & Population Health. (2018). Bronx Community Health Dashboard: Nutrition, physical activity and obesity.

Morgan, O.W., Bramley, A., Fowlkes, A., et al. (2010). Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A(H1N1) disease. PLoS One, 5(3), e9694. DOI:

NCD Risk Factor Collaboration (NCD-RisC). (2016). Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants [published correction appears in Lancet. Lancet, 387(10026), 1377-1396. DOI:

NCD Risk Factor Collaboration (NCD-RisC). (2019). Rising rural body-mass index is the main driver of the global obesity epidemic in adults. Nature, 569(7755), 260-264. DOI:

Ni, Y.N., Luo, J., Yu, H., et al. (2017). Can body mass index predict clinical outcomes for patients with acute lung injury/acute respiratory distress syndrome? A meta-analysis. Crit Care., 21(1), DOI:

NYC Health. (2020). Promoting and Protecting the City's Health. COVID-19: Data.

NYC Health. (2022). COVID-19: Data.

O'Brien, J.M. Jr., Welsh, C.H., Fish, R.H., Ancukiewicz, M., Kramer, A.M. (2004). National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome Network. Excess body weight is not independently associated with outcome in mechanically ventilated patients with acute lung injury. Ann Intern Med., 140(5), 338-345. DOI:

Ornell, F., Schuch, J.B., Sordi, A.O., Kessler, F.H.P. (2020). "Pandemic fear" and COVID-19: mental health burden and strategies. Braz J Psychiatry, 42(3), 232–235. DOI:

Petrilli, C.M., Jones, S.A., Yang, J., et al. (2020). Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ, 369(m1966). DOI:

Popkin, B.M., Corvalan, C., Grummer-Strawn, L.M. (2020). Dynamics of the double burden of malnutrition and the changing nutrition reality. Lancet, 395(10217), 65-74. DOI:

Puelles, V.G., Lütgehetmann, M., Lindenmeyer, M.T., et al. (2020). Multiorgan and Renal Tropism of SARS-CoV-2. N Engl J Med., 383(6), 590-592. DOI:

Rasouli, N., Kern, P.A. (2008). Adipocytokines and the metabolic complications of obesity. J Clin Endocrinol Metab., 93(11 Suppl 1), S64-S73. DOI:

Reilev, M., Kristensen, K.B., Pottegård, A., et al. (2020). Characteristics and predictors of hospitalization and death in the first 11 122 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: a nationwide cohort. Int J Epidemiol., 49(5), 1468-1481. DOI:

Rosenberg, E.S., Dufort, E.M., Blog, D.S., et al. (2020). COVID-19 Testing, Epidemic Features, Hospital Outcomes, and Household Prevalence, New York State-March 2020. Clin Infect Dis., 71(8), 1953-1959.

Roth, J., Sahota, N., Patel, P., et al. (2017). Obesity paradox, obesity orthodox, and the metabolic syndrome: An approach to unity. Mol Med., 22, 873-885. DOI:

Rothe, C., Schunk, M., Sothmann, P., et al. (2020). Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. N Engl J Med., 382(10), 970-971. DOI:

Sattar, N., McInnes, I.B., McMurray, J.J.V. (2020). Obesity Is a Risk Factor for Severe COVID-19 Infection: Multiple Potential Mechanisms. Circulation, 142(1), 4-6. DOI:

Sheetz, M.J., King, G.L. (2002). Molecular understanding of hyperglycemia's adverse effects for diabetic complications. JAMA, 288(20), 2579-2588. DOI:

Siddiqi, H.K., Mehra, M.R. (2020). COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal. J Heart Lung Transplant, 39(5), 405-407. DOI:

Singla, P., Bardoloi, A., Parkash, A.A. (2010). Metabolic effects of obesity: A review. World J Diabetes., 1(3), 76-88. DOI:

Stefan, N., Birkenfeld, A.L., Schulze, M.B., Ludwig, D.S. (2020). Obesity and impaired metabolic health in patients with COVID-19. Nat Rev Endocrinol., 16(7), 341-342. DOI:

Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., Zhao, Y., Li, Y., Wang, X., Peng, Z. (2020). Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA, 323(11), 1061-1069. DOI:

WCRF. (2018a). Diet, nutrition, physical activity and cancer: a global perspective: A summary of the third expert report. World Cancer Research Fund/American Institute for Cancer Research.

WCRF. (2018b). Diet, nutrition, physical activity and cancer: a global perspective. Continuous Update Project Expert Report. World Cancer Research Fund/American Institute for Cancer Research.

Webb Hooper, M., Nápoles, A.M., Pérez-Stable, E.J. (2020). COVID-19 and Racial/Ethnic Disparities. JAMA, 323(24), 2466-2467. DOI:

WHO. (2020). World Health Organization Coronavirus disease 2019 (COVID-19) situation report – 87.

Wiersinga, W.J., Rhodes, A., Cheng, A.C., Peacock, S.J., Prescott, H.C. (2020). Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA, 324(8), 782-793. DOI:

Wright, G.J., Cherwinski, H., Foster-Cuevas, M., et al. (2003). Characterization of the CD200 receptor family in mice and humans and their interactions with CD200. J Immunol., 171(6), 3034-3046. DOI:

Wu, C., Chen, X., Cai, Y., et al. (2020). Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med., 180(7), 934-943. DOI:

Wu, Z., McGoogan, J.M. (2020). Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. The JAMA, 323(13), 1239-1242. DOI:

Yancy, C.W. (2020). COVID-19 and African Americans. JAMA, 323(19), 1891-1892. DOI:

Yang, W., Cao, Q., Qin, L., Wang, X., Cheng, Z., Pan, A., Dai, J., Sun, Q., Zhao, F., Qu, J., Yan, F. (2020). Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19): a multi-center study in Wenzhou city, Zhejiang, China. Journal of Infection, 80(4), 388-393. DOI:

Zhao, Y., Zhao, Z., Wang, Y., Zhou, Y., Ma, Y., Zuo, W. (2020). Single-cell RNA expression profiling of ACE2, the receptor of SARS-CoV-2. bioRxiv. DOI:

Zhao, Y., Zhao, Z., Wang, Y., Zhou, Y., Ma, Y., Zuo, W. (2021). Single-Cell RNA Expression Profiling of ACE2, the Receptor of SARS-CoV-2. Am J Respir Crit Care Med., 202(5), 756-759. DOI:

Zhi, G., Xin, W., Ying, W., Guohong, X., Shuying, L. (2016). "Obesity Paradox" in acute respiratory distress syndrome: A Systematic Review and Meta-Analysis. PLoS One, 11(9), e0163677. DOI:

Zhou, F., Yu, T., Du, R., et al. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet, 395(10229), 1054-1062.

Zhou, F., Yu, T., Du, R., et al. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet, 395(10229), 1054-1062. DOI:

Zhu, L., She, Z.G., Cheng, X., et al. (2020). Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes. Cell Metab., 31(6), 1068-1077. DOI:





How to Cite

Bhagavan, M. S., Karnatapu, S. C., Doke, S., Amalathasan, T., Amalathasan, T., & Ashokkumar, C. (2022). Morbidity and Mortality of COVID in Relation to Age, Sex and BMI. ABC Journal of Advanced Research, 11(1), 33-46.

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 10 > >>